Category Archives: Cancer Treatment

Providing Top-Notch Care with Top-Notch Tech – Founded by Eric Lefkofsky

Tempus is a technology company with the largest operating system to database clinical data in a way that can be interpreted and accessible for analytical purposes. Physicians are able to analyze the data in order to provide a more personalized treatment plan for cancer patients. This central database structures big data such as clinical records, pathology images and radiology scans, with a capacity of 50,000 records per year. The goal at Tempus is to provide physicians a platform to make real-time decisions based on historical, past-patient data. The best technology in the hands of physicians leads to giving the best care options available. Keeping up with technology is critical for research in this day and age and Tempus is empowering that.

Eric Lefkofsky is the co-founder and CEO at Tempus and has aided in bridging the gap between technology and physician care, making healthcare systems more effective in how physicians treat diseases.

Eric and Liz Lefkofsky founded the Lefkofsky Family Foundation in 2006, based in Chicago. Their endeavors touch across education, tech, health and the arts and culture fields. In support of education, they donate to multiple schools, after-school programs, and organizations that help to develop teachers. One of the endeavors they participate in is called Moneythink, which provides mentors to teach financial education in urban schools. The Lefkofsky Family Foundation also donates toward research into various health areas such as treatments for thyroid cancer, lung cancer, leukemia, Crohn’s disease, Alzheimer’s, Lupus, and food allergies.

The Lefkofsky Family Foundation gives to arts and culture including Chicago museums, dance, and theatre companies and public radio stations. In support of technology, the Lefkofsky Family Foundation partnered with Google and Motorola, creating FEMtech which hopes to encourage more female tech entrepreneurs into the field.

Eric Lefkofsky is active across social media platforms, blogging about curing diseases and has made it his mission to promote just that.

Eric Lefkofsk’s Facebook Page: www.facebook.com/eplefkofsky/

How Dr. David Samadi Became America’s Favorite Celebrity Doctor

There are alot of celebrity doctors on TV. There is even a TV show called “The Doctors.” However, there is one doctor who has become one of the top go-to medical experts in the media. That doctor, Dr. David Samadi, has become one of the most popular doctors in print, on the web and on TV.So who exactly is Dr. Davd Samdi and why is he so popular? Dr. Samadi is best known as the Chief of Robotic Surgery at Lenox Hill Hospital. In addition to his professional work, Dr. Samadi keeps a high profile in the media. In fact, Dr. Samadi has his own educational site online at DrSamadiTV.com.

On this website, one can find everything from a frequently updated video area to a medical symptom checker.Dr. Samadi is also well known for his presence on various TV shows including Fox News. When there is a medical issue in the celebrity world, the media always seems to ask for Dr. Samadi’s expert opinion first. In fact, Dr. Samadi was one of the only doctors to comment on Senatorial candidate Mitt Romney’s successful prostate surgery. In an article, Dr. Samadi commented that Mr. Romney made the right choice to seek surgery over chemotherapy. In another profile, Dr. Samadi talked about a new approach he is undertaking to remove cancerous prostates.

The procedure is known as the Samadi Modified Advanced Robotic Technique or the(SMART) procedure. Using robotic surgery allows Dr. Samadi to be more precise with his procedure and reduce the risk of side effects. Today, Dr. Samadi is only a handful of surgeons who are qualified to perform robotic surgery in the United States.When asked about his typical day, Dr. Samadi mentions that he usually gets up at around 4:30 AM and that he is in his office by 6 in the morning. From there, Dr. Samadi is on his feet all day, usually performing 2 to 3 surgeries each week. It is this dedicated approach to his work that has made Dr. David Samadi so popular with patients, not to mention those who follow his advice and wisdom in the media.

Eric Lefkofsky: Fighting Cancer with New Technologies

Cancer is one of the deadliest diseases in the history of humanity. For ages, it has claimed the lives of billions of people. The disease is very tricky, as it conditions the body that having cancer is a normal function inside the body until it gives out its final blow killing of victim. Scientists around the world have been working together to fight off the disease, and one man named Eric Lefkofsky has even founded a tech company only dedicated to putting an end to cancer. Tempus Labs was established to improve the way on how patients who are suffering from cancer can be diagnosed and eventually treated. Eric Lefkofsky stands as the company’s chief executive officer, and he managed to propel the company to become one of the top tech companies in Chicago.

Tempus Labs gather data from different cancer patients around the world. With the technology that Eric Lefkofsky developed, the company can organize all of the data sent to them and formulating various ways on how to diagnose future patients who will develop the disease. Through the gathering and organizing of data, it is possible that Tempus Labs will be able to develop the best treatment for a particular patient. It is also lauded by scientists because Tempus Labs allow the storage of sensitive data that can end up being lost or destroyed.

The traditional medical record of patients with cancer has been used repeatedly for ages because doctors can just look at the symptoms and judge whether the patient is having the same kind of disease. With the technology developed by Tempus, it is possible for the patient data to be analyzed by the computer, and new patterns and algorithms will be developed to personalize the treatment method for a patient. It is an amazing technology, and Eric Lefkofsky thanked everyone who helped him realize the project.

Eric Lefkofsky is hoping that the technology he created would save lives in the future. He is also putting his trust to future scientists in improving the project that he created. Tempus Labs continues to gather data, and it now has a gargantuan data storage facility that has millions of data stored.

For details: www.lightbank.com/team/eric-lefkofsky

Clay Siegall, Improving The Lives Of Cancer Patients

Clay Siegall is the co-founder of Seattle Genetics since 1998. He started the company with the idea of improving people’s lives by using targeted therapies to kill cancer cells. Clay Siegall is a trained scientist who built Seattle Genetics to develop drug practices, perform extensive research and improve your quality of life. Under his leadership he has helped Seattle Genetics create ADCETRIS, their first FDA approved product for the treatment of cancer. ADCETRIS is a global brand that is currently approved in over 70 countries. They have also entered into multiple licenses for their ADCETRIS technology, including AbbVie, Pfizer, Astellas, GlaxoSmithKline and Genentech (Roche). Using Seattle Genetics’ technology, there are more than 20 ADC’s currently in clinical development. Clay Siegall is also responsible for the capital-raising activities for Seattle Genetics. He has helped secure over $1 billion through private and public financing. Clay has worked for the National Institutes of Health, National Cancer Institute and the Bristol-Myers Squibb Pharmaceutical Research Institute. He has been honored with the University of Maryland Alumnus of the Year for Computer, Math and Natural Sciences award and the 2012 Pacific Northwest Ernst & Young Entrepreneur of the Year award. He has written over 70 publications and graduated from George Washington University with a Ph.D. in Genetics. Siegall also have a B.S. in Zoology from the University of Maryland.

Seattle Genetics is one of the largest oncology biotechnology company in the Pacific Northwest. Their innovative ADC technology combines potent cell eliminating agents, linker systems and monoclonal antibodies to kill cancer. Seattle Genetics has proven to improve the outcomes of their patients living with cancer. They are becoming the leader in transforming cancer therapy through its advanced research into ADC technology.